# GORTEC 2014-04 (NCT03070366)

> Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: head and neck squamous cell carcinoma with oligometastases

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03070366
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
- Conditions: Head and Neck Squamous Cell Carcinoma
- Interventions: Chemotherapy; Stereotactic radiotherapy
- Enrollment: 78
- Primary outcome: Overall Survival without quality of life deterioration

## Indexed commentary on GORTEC 2014-04 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X
- 1 podcast episode

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=gortec-2014-04-nct03070366